Author | Asher A. Chanan-Khan, MD | OncLive

Author | Asher A. Chanan-Khan, MD

Articles

Dr. Chanan-Khan on Ibrutinib as Backbone of Treatment for CLL

August 25, 2015

Video

Asher A. Chanan-Khan, MD, chair, Hematology/Oncology, Mayo Clinic in Florida, discusses ibrutinib as a backbone of treatment for patients with chronic lymphocytic leukemia (CLL).

Dr. Chanan-Khan Discusses Ibrutinib and BR in CLL

June 23, 2015

Video

Asher A. Chanan-Khan, MD, chair, Hematology/Oncology, Cancer Center, Mayo Clinic, discusses ibrutinib (Imbruvica) combined with rituximab and bendamustine (BR) as treatment of chronic lymphocytic leukemia (CLL) from a mechanism of action point of view.

Dr. Chanan-Khan on Ibruitinib Combined with BR in CLL/SLL

May 30, 2015

Video

Asher A. Chanan-Khan, MD, chair, Hematology/Oncology, Cancer Center, Mayo Clinic, discusses a recent study that examined ibrutinib combined with bendamustine and ritxuimab (BR) in patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

x